# Clinical Study Comparing Diosmin vs Rebamipide as Adjuvant Therapies vs Conventional Therapy in Patients With Rheumatoid Arthritis

> **NCT07745426** · PHASE2 · RECRUITING · sponsor: **Tanta University** · enrollment: 66 (estimated)

## Conditions studied

- Rheumatoid Arthritis (RA)

## Interventions

- **DRUG:** Diosmin
- **DRUG:** Rebamipide 100mg
- **DRUG:** Convential medical treatment

## Key facts

- **NCT ID:** NCT07745426
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2027-08-01
- **Final completion:** 2027-08-01
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07745426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07745426, "Clinical Study Comparing Diosmin vs Rebamipide as Adjuvant Therapies vs Conventional Therapy in Patients With Rheumatoid Arthritis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07745426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*